Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 100
Filtrar
1.
Drugs Today (Barc) ; 47(3): 207-14, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21494698

RESUMO

Current pneumococcal conjugate vaccines (PCVs) are highly effective in preventing serotype-specific pneumococcal disease; however, they are relatively expensive and complicated to produce. Furthermore, PCVs do not cover all disease-causing pneumococcal serotypes. While current PCVs are available in industrialized countries and with external assistance in some low-income countries, alternative, more intrinsically affordable pneumococcal vaccines are essential for achieving more widespread use and coverage in resource-limited settings, where vaccines are often inaccessible and need is greatest. This review article describes a number of approaches to develop new PCVs designed to meet this urgent need.


Assuntos
Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas/imunologia , Países em Desenvolvimento , Humanos , Vacinas Conjugadas/imunologia
2.
Infect Immun ; 74(8): 4566-72, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16861643

RESUMO

The development of novel vaccine strategies supplementing Mycobacterium bovis BCG (BCG) constitutes an urgent research challenge. To identify potential subunit vaccine candidates, we have tested a series of eight recently identified Mycobacterium tuberculosis antigens in M. bovis-infected and BCG-vaccinated cattle. These antigens were characterized on the basis of their ability to induce in vitro gamma interferon responses in infected or BCG-vaccinated calves. We were able to establish a hierarchy of these antigens based on how frequently they were recognized in both groups of animals. In particular, we were able to prioritize frequently recognized proteins like Rv0287, Rv1174, and Rv1196 for future evaluation as subunit vaccines to be used in BCG-protein heterologous prime-boost vaccination scenarios. In addition, the antigen most dominantly recognized in M. bovis-infected cattle in this study, Rv3616c, was significantly less frequently recognized by BCG vaccinees and could be a target to improve BCG, for example, by increasing its secretion, in a recombinant BCG vaccine.


Assuntos
Antígenos de Bactérias/imunologia , Vacina BCG/administração & dosagem , Mycobacterium bovis/imunologia , Tuberculose Bovina/imunologia , Sequência de Aminoácidos , Animais , Antígenos de Bactérias/genética , Vacina BCG/imunologia , Bovinos , Humanos , Interferon gama/biossíntese , Leucócitos Mononucleares/imunologia , Dados de Sequência Molecular , Peptídeos/química , Peptídeos/imunologia , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Vacinas contra a Tuberculose , Tuberculose Bovina/microbiologia , Tuberculose Bovina/prevenção & controle , Vacinação
3.
Tuberculosis (Edinb) ; 83(1-3): 213-9, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12758214

RESUMO

There have been many new promising approaches to developing human vaccines against tuberculosis (TB). Advances in gene and antigen identification, availability of genome sequences, a greater understanding of immune mechanisms in resistance to TB, the development of adjuvants and delivery systems to stimulate T-cell immunity, and increased funding from public and private agencies are some of the reasons for progress in this area. Dozens of vaccine candidates have been tested in animal models in recent years, and several of these are poised to move into clinical trials in the next several years. Thus, there is renewed optimism for the potential of developing new and improved TB vaccines.


Assuntos
Vacinas contra a Tuberculose , Tuberculose Pulmonar/prevenção & controle , Adjuvantes Imunológicos , Animais , Antígenos de Bactérias/imunologia , Modelos Animais de Doenças , Humanos , Mycobacterium tuberculosis/imunologia
4.
J Immunol ; 166(10): 6227-35, 2001 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-11342645

RESUMO

The development of an effective vaccine against Mycobacterium tuberculosis is a research area of intense interest. Mounting evidence suggests that protective immunity to M. tuberculosis relies on both MHC class II-restricted CD4(+) T cells and MHC class I-restricted CD8(+) T cells. By purifying polypeptides present in the culture filtrate of M. tuberculosis and evaluating these molecules for their ability to stimulate PBMC from purified protein derivative-positive healthy individuals, we previously identified a low-m.w. immunoreactive T cell Ag, Mtb 8.4, which elicited strong Th1 T cell responses in healthy purified protein derivative-positive human PBMC and in mice immunized with recombinant Mtb 8.4. Herein we report that Mtb 8.4-specific T cells can be detected in mice immunized with the current live attenuated vaccine, Mycobacterium bovis-bacillus Calmette-Guérin as well as in mice infected i.v. with M. tuberculosis. More importantly, immunization of mice with either plasmid DNA encoding Mtb 8.4 or Mtb 8.4 recombinant protein formulated with IFA elicited strong CD4(+) T cell and CD8(+) CTL responses and induced protection on challenge with virulent M. tuberculosis. Thus, these results suggest that Mtb 8.4 is a potential candidate for inclusion in a subunit vaccine against TB.


Assuntos
Antígenos de Bactérias/administração & dosagem , Vacina BCG/administração & dosagem , Proteínas de Bactérias , Mycobacterium tuberculosis/imunologia , Subpopulações de Linfócitos T/imunologia , Tuberculose/prevenção & controle , Animais , Anticorpos Antibacterianos/biossíntese , Antígenos de Bactérias/imunologia , Vacina BCG/imunologia , Células Cultivadas , Testes Imunológicos de Citotoxicidade , DNA Bacteriano/administração & dosagem , DNA Bacteriano/imunologia , Epitopos de Linfócito T/imunologia , Imunoglobulina G/biossíntese , Injeções Subcutâneas , Interferon gama/biossíntese , Ativação Linfocitária , Macrófagos/imunologia , Macrófagos/microbiologia , Camundongos , Camundongos Endogâmicos C57BL , Mycobacterium bovis/imunologia , Subpopulações de Linfócitos T/microbiologia , Linfócitos T Citotóxicos/imunologia , Linfócitos T Citotóxicos/microbiologia , Células Th1/imunologia , Células Th1/microbiologia , Tuberculose/imunologia , Vacinas de DNA/administração & dosagem , Vacinas de DNA/imunologia , Vacinas Sintéticas/administração & dosagem , Vacinas Sintéticas/imunologia
5.
J Immunol ; 166(1): 439-46, 2001 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-11123322

RESUMO

Previous studies in murine and human models have suggested an important role for HLA Ia-restricted CD8(+) T cells in host defense to Mycobacterium tuberculosis (Mtb). Therefore, understanding the Ags presented via HLA-Ia will be important in understanding the host response to Mtb and in rational vaccine design. We have used monocyte-derived dendritic cells in a limiting dilution analysis to generate Mtb-specific CD8(+) T cells. Two HLA-Ia-restricted CD8(+) T cell clones derived by this method were selected for detailed analysis. One was HLA-B44 restricted, and the other was HLA-B14 restricted. Both were found to react with Mtb-infected, but not bacillus Calmette-Guérin-infected, targets. For both these clones, the Ag was identified as culture filtrate protein 10 (CFP10)/Mtb11, a 10.8-kDa protein not expressed by bacillus Calmette-Guérin. Both clones were inhibited by the anti-class I Ab and anti-HLA-B,C Abs. Using a panel of CFP10/Mtb11-derived 15-aa peptides overlapping by 11 aa, the region containing the epitopes for both clones has been defined. Minimal 10-aa epitopes were defined for both clones. CD8(+) effector cells specific for these two epitopes are present at high frequency in the circulating pool. Moreover, the CD8(+) T cell response to CFP10/Mtb11 can be largely accounted for by the two epitopes defined herein, suggesting that this is the immunodominant response for this purified protein derivative-positive donor. This study represents the first time CD8(+) T cells generated against Mtb-infected APC have been used to elucidate an Mtb-specific CD8(+) T cell Ag.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Epitopos de Linfócito T/imunologia , Antígenos HLA/imunologia , Antígenos de Histocompatibilidade Classe I/imunologia , Mycobacterium tuberculosis/imunologia , Sequência de Aminoácidos , Anticorpos Bloqueadores/farmacologia , Anticorpos Monoclonais/farmacologia , Apresentação de Antígeno , Antígenos de Bactérias/sangue , Antígenos de Bactérias/imunologia , Antígenos de Bactérias/metabolismo , Proteínas de Bactérias/sangue , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/metabolismo , Linfócitos T CD8-Positivos/metabolismo , Linfócitos T CD8-Positivos/microbiologia , Células Clonais , Testes Imunológicos de Citotoxicidade , Mapeamento de Epitopos , Epitopos de Linfócito T/metabolismo , Antígenos HLA/metabolismo , Antígenos de Histocompatibilidade Classe I/metabolismo , Humanos , Células Jurkat , Contagem de Linfócitos , Dados de Sequência Molecular , Tuberculina/sangue
6.
J Immunol ; 165(12): 7140-9, 2000 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-11120845

RESUMO

Infection of C57BL/6 mice with Mycobacterium tuberculosis results in the development of a progressive disease during the first 2 wk after challenge. Thereafter, the disease is controlled by the emergence of protective T cells. We have used this infection model in conjunction with direct T cell expression cloning to identify Ags involved with the early control of the disease. A protective M. tuberculosis-specific CD4 T cell line derived from mice at 3 wk postchallenge was used to directly screen an M. tuberculosis genomic expression library. This screen resulted in the identification of a genomic clone comprising two putative adjacent genes with predicted open reading frames of 10 and 41 kDa, MTB10 and MTB41, respectively (the products of Rv0916c and Rv0915c, respectively, in the TubercuList H37Rv database). MTB10 and MTB41 belong to the PE and PPE family of proteins recently identified to comprise 10% of the M. tuberculosis genome. Evaluation of the recombinant proteins revealed that MTB41, but not MTB10, is the Ag recognized by the cell line and by M. tuberculosis-sensitized human PBMC. Moreover, C57BL/6 mice immunized with MTB41 DNA developed both CD4- (predominantly Th1) and CD8-specific T cell responses to rMTB41 protein. More importantly, immunization of C57BL/6 mice with MTB41 DNA induced protection against infection with M. tuberculosis comparable to that induced by bacillus Calmette-Guérin. Thus, the use of a proven protective T cell line in conjunction with the T cell expression cloning approach resulted in the identification of a candidate Ag for a subunit vaccine against tuberculosis.


Assuntos
Antígenos de Bactérias/administração & dosagem , Antígenos de Bactérias/genética , Antígenos de Bactérias/imunologia , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/imunologia , Linfócitos T/metabolismo , Linfócitos T/microbiologia , Tuberculose/prevenção & controle , Animais , Antígenos de Bactérias/biossíntese , Vacina BCG/administração & dosagem , Vacina BCG/genética , Vacina BCG/imunologia , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/imunologia , Técnicas de Cultura de Células , Linhagem Celular , Células Cultivadas , Clonagem Molecular/métodos , Epitopos de Linfócito T/imunologia , Regulação Bacteriana da Expressão Gênica/imunologia , Biblioteca Genômica , Humanos , Injeções Intramusculares , Camundongos , Camundongos Endogâmicos C57BL , Baço/citologia , Baço/imunologia , Tuberculose/genética , Tuberculose/imunologia , Vacinas de DNA/administração & dosagem , Vacinas de DNA/imunologia
7.
J Clin Microbiol ; 38(9): 3285-90, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10970372

RESUMO

In order to identify antigens that may be used in the serodiagnosis of active tuberculosis (TB), we screened a Mycobacterium tuberculosis genomic expression library with a pool of sera from patients diagnosed with active pulmonary TB. The sera used lacked reactivity with a recombinant form of the M. tuberculosis 38-kDa antigen (r38kDa), and the goal was to identify antigens that might complement r38kDa in a serodiagnostic assay. Utilizing this strategy, we identified a gene, previously designated lhp, which encodes a 100-amino-acid protein referred to as culture filtrate protein 10 (CFP-10). The lhp gene is located directly upstream of esat-6, within a region missing in M. bovis BCG. Immunoblot analysis demonstrated that CFP-10 is present in M. tuberculosis CFP, indicating that it is likely a secreted or shed antigen. Purified recombinant CFP-10 (rCFP-10) was shown to be capable of detecting specific antibody in a percentage of TB patients that lack reactivity with r38kDa, most notably in smear-negative cases, where sensitivity was increased from 21% for r38kDa alone to 40% with the inclusion of rCFP-10. In smear-positive patient sera, sensitivity was increased from 49% for r38kDa alone to 58% with the inclusion of rCFP-10. In addition, rCFP-10 was shown to be a potent T-cell antigen, eliciting proliferative responses and gamma interferon production from peripheral blood mononuclear cells in 70% of purified protein derivative-positive individuals without evident disease. The responses to this antigen argue for the inclusion of rCFP-10 in a polyvalent serodiagnostic test for detection of active TB infection. rCFP-10 could also contribute to the development of a recombinant T-cell diagnostic test capable of detecting exposure to M. tuberculosis.


Assuntos
Antígenos de Bactérias/imunologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/imunologia , Mycobacterium tuberculosis/imunologia , Tuberculose Pulmonar/diagnóstico , Adolescente , Adulto , Sequência de Aminoácidos , Anticorpos Antibacterianos/sangue , Antígenos de Bactérias/química , Antígenos de Bactérias/genética , Proteínas de Bactérias/química , Proteínas de Bactérias/isolamento & purificação , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Immunoblotting , Ativação Linfocitária , Masculino , Dados de Sequência Molecular , Mycobacterium bovis/genética , Mycobacterium bovis/imunologia , Mycobacterium tuberculosis/genética , Proteínas Recombinantes/química , Proteínas Recombinantes/imunologia , Tuberculose Pulmonar/microbiologia
8.
J Immunol ; 165(2): 925-30, 2000 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-10878367

RESUMO

Previous studies in mice and humans models have suggested an important role for CD8+ T cells in host defense to Mycobacterium tuberculosis (Mtb). In humans, CD8+ Mtb-reactive T cells have been described that are HLA-A2-, B52-, as well as CD1-restricted. Recently, we have described Mtb-specific CD8+ T cells that are neither HLA-A-, B-, or C- nor group 1 CD1-restricted. At present, little is known about the relative contribution of each of these restriction specificities to the overall CD8+ response to Mtb. An IFN-gamma enzyme-linked immunospot assay was used to determine the frequency of Mtb-reactive CD8+ T cells directly from PBMC. The effector cell frequency among five healthy purified protein derivative-positive subjects was 1/7,600 +/- 4,300 compared with 1/16,000 +/- 7,000 in six purified protein derivative-negative controls. To determine the frequencies of classically, CD1-, and nonclassically restricted cells, a limiting dilution analysis was performed. In one purified protein derivative-positive subject, 192 clones were generated using Mtb-infected dendritic cells (DC). Clones were assessed for reactivity against control autologous DC, Mtb-infected autologous DC, and HLA-mismatched CD1+ targets (DC), as well as HLA-mismatched CD1- targets (macrophages). Of the 96 Mtb-reactive CD8+ T cell clones, four (4%) were classically restricted and 92 (96%) were nonclassically restricted. CD1-restricted cells were not detected. Of the classically restricted cells, two were HLA-B44 restricted and one was HLA-B14 restricted. These results suggest that while classically restricted CD8+ lymphocytes can be detected, they comprise a relatively small component of the overall CD8+ T cell response to Mtb. Further definition of the nonclassical response may aid development of an effective vaccine against tuberculosis.


Assuntos
Linfócitos T CD8-Positivos/imunologia , Linfócitos T CD8-Positivos/microbiologia , Antígenos HLA/imunologia , Mycobacterium tuberculosis/imunologia , Células Apresentadoras de Antígenos/imunologia , Células Apresentadoras de Antígenos/metabolismo , Células Apresentadoras de Antígenos/microbiologia , Antígenos CD1/imunologia , Linfócitos T CD8-Positivos/metabolismo , Células Clonais , Células Dendríticas/imunologia , Células Dendríticas/metabolismo , Células Dendríticas/microbiologia , Ensaio de Imunoadsorção Enzimática , Humanos , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Leucócitos Mononucleares/microbiologia , Ativação Linfocitária/imunologia , Contagem de Linfócitos , Macrófagos/imunologia , Macrófagos/metabolismo , Macrófagos/microbiologia , Subpopulações de Linfócitos T/imunologia , Subpopulações de Linfócitos T/metabolismo , Subpopulações de Linfócitos T/microbiologia , Linfócitos T Reguladores/imunologia , Linfócitos T Reguladores/metabolismo , Linfócitos T Reguladores/microbiologia , Tuberculina/imunologia , Tuberculose/imunologia
9.
J Exp Med ; 191(3): 551-60, 2000 Feb 07.
Artigo em Inglês | MEDLINE | ID: mdl-10662800

RESUMO

Development of a subunit vaccine for Mycobacterium tuberculosis (Mtb) is likely to be dependent on the identification of T cell antigens that induce strong proliferation and interferon gamma production from healthy purified protein derivative (PPD)(+) donors. We have developed a sensitive and rapid technique for screening an Mtb genomic library expressed in Escherichia coli using Mtb-specific CD4(+) T cells. Using this technique, we identified a family of highly related Mtb antigens. The gene of one family member encodes a 9.9-kD antigen, termed Mtb9.9A. Recombinant Mtb9.9A protein, expressed and purified from E. coli, elicited strong T cell proliferation and IFN-gamma production by peripheral blood mononuclear cells from PPD(+) but not PPD(-) individuals. Southern blot analysis and examination of the Mtb genome sequence revealed a family of highly related genes. A T cell line from a PPD(+) donor that failed to react with recombinant Mtb9.9A recognized one of the other family members, Mtb9.9C. Synthetic peptides were used to map the T cell epitope recognized by this line, and revealed a single amino acid substitution in this region when compared with Mtb9.9A. The direct identification of antigens using T cells from immune donors will undoubtedly be critical for the development of vaccines to several intracellular pathogens.


Assuntos
Antígenos de Bactérias/genética , Linfócitos T CD4-Positivos/metabolismo , Mycobacterium tuberculosis/imunologia , Sequência de Aminoácidos , Antígenos de Bactérias/química , Antígenos de Bactérias/imunologia , Vacinas Bacterianas , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/microbiologia , Linhagem Celular , Clonagem Molecular , Escherichia coli/genética , Escherichia coli/metabolismo , Genes Bacterianos , Biblioteca Genômica , Humanos , Dados de Sequência Molecular
10.
Infect Immun ; 67(8): 3998-4007, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10417166

RESUMO

Culture filtrate proteins (CFP) of Mycobacterium tuberculosis have been shown to contain immunogenic components that elicit at least partial protective immunity against Mycobacterium infection. To clone genes encoding some of the immunogenic proteins, we made a high-titer rabbit anti-CFP serum and used it to screen an M. tuberculosis genomic expression library in Escherichia coli. In this paper, we describe the molecular cloning of two new protein components of CFP and identified them as members of the serine protease gene family. Their open reading frames contain N-terminal hydrophobic secretory signals consistent with their detection in CFP. The predicted molecular masses of the mature, fully processed forms of both antigens are approximately 32 kDa, in agreement with their observed sizes on immunoblots of CFP probed with polyclonal rabbit antisera made to the recombinant proteins. Thus, these proteins have been designated MTB32A and MTB32B. Interestingly, and despite 66% amino acid sequence homology between the two proteins, polyclonal rabbit antisera made to each of the recombinant proteins were found to be specific for the respective immunizing antigens. The recombinant proteins were also evaluated in in vitro assays with donor peripheral blood mononuclear cells (PBMC) from healthy purified protein derivative (PPD)-positive individuals of diverse ethnic backgrounds. MTB32A but not MTB32B stimulated PBMC from healthy PPD-positive donors but not from PPD-negative donors to proliferate and secrete gamma interferon. MTB32A is encoded by a single-copy gene which is present in both virulent and avirulent strains of the M. tuberculosis complex and the BCG strain of Mycobacterium bovis but absent in the environmental mycobacterial species tested. In addition, nucleotide sequence comparison of mtb32a of the avirulent H37Ra strain and the virulent Erdman strain, as well as with the corresponding sequences (identified in the databases) of strain H37Rv and the clinical isolate CSU93, revealed 100% identity. MTB32A, therefore, represents a candidate for inclusion in subunit vaccine development. Finally, the possible role of MTB32 serine proteases as a virulence factor(s) during Mycobacterium spp. infection is discussed.


Assuntos
Antígenos de Bactérias/imunologia , Proteínas de Bactérias/imunologia , Mycobacterium tuberculosis/imunologia , Serina Endopeptidases/imunologia , Sequência de Aminoácidos , Animais , Antígenos de Bactérias/química , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Sequência de Bases , Western Blotting , Clonagem Molecular , Sequência Conservada , Humanos , Interferon gama/biossíntese , Ativação Linfocitária , Dados de Sequência Molecular , Coelhos , Serina Endopeptidases/química , Serina Endopeptidases/genética
11.
Infect Immun ; 67(6): 2941-50, 1999 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10338503

RESUMO

We have used expression screening of a genomic Mycobacterium tuberculosis library with tuberculosis (TB) patient sera to identify novel genes that may be used diagnostically or in the development of a TB vaccine. Using this strategy, we have cloned a novel gene, termed mtb39a, that encodes a 39-kDa protein. Molecular characterization revealed that mtb39a is a member of a family of three highly related genes that are conserved among strains of M. tuberculosis and Mycobacterium bovis BCG but not in other mycobacterial species tested. Immunoblot analysis demonstrated the presence of Mtb39A in M. tuberculosis lysate but not in culture filtrate proteins (CFP), indicating that it is not a secreted antigen. This conclusion is strengthened by the observation that a human T-cell clone specific for purified recombinant Mtb39A protein recognized autologous dendritic cells infected with TB or pulsed with purified protein derivative (PPD) but did not respond to M. tuberculosis CFP. Purified recombinant Mtb39A elicited strong T-cell proliferative and gamma interferon responses in peripheral blood mononuclear cells from 9 of 12 PPD-positive individuals tested, and overlapping peptides were used to identify a minimum of 10 distinct T-cell epitopes. Additionally, mice immunized with mtb39a DNA have shown increased protection from M. tuberculosis challenge, as indicated by a reduction of bacterial load. The human T-cell responses and initial animal studies provide support for further evaluation of this antigen as a possible component of a subunit vaccine for M.tuberculosis.


Assuntos
Antígenos de Bactérias/genética , Genes Bacterianos , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/imunologia , Linfócitos T/imunologia , Tuberculose/imunologia , Adolescente , Sequência de Aminoácidos , Animais , Antígenos de Bactérias/imunologia , Vacina BCG/imunologia , Células Dendríticas/imunologia , Feminino , Humanos , Leucócitos Mononucleares/imunologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Dados de Sequência Molecular , Família Multigênica , Coelhos , Tuberculose/sangue , Tuberculose/microbiologia , Tuberculose/prevenção & controle , Vacinação , Vacinas de DNA/imunologia
12.
J Immunol ; 161(5): 2356-64, 1998 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-9725231

RESUMO

Polypeptide Ags present in the culture filtrate of Mycobacterium tuberculosis were purified and evaluated for their ability to stimulate PBMC from purified protein derivative (PPD)-positive healthy donors. One such Ag, which elicited strong proliferation and IFN-gamma production, was further characterized. The N-terminal amino acid sequence of this polypeptide was determined and used to design oligonucleotides for screening a recombinant M. tuberculosis genomic DNA library. The gene (Mtb 8.4) corresponding to the identified polypeptide was cloned, sequenced, and expressed in Escherichia coli. The predicted m.w. of the recombinant protein without its signal peptide was 8.4 kDa. By Southern analysis, the DNA encoding this mycobacterial protein was found in the M. tuberculosis substrains H37Rv, H37Ra, Erdman, and "C" strain, as well as in certain other mycobacterial species, including Mycobacterium avium and Mycobacterium bovis BCG (bacillus Calmette-Guerin, Pasteur). The Mtb 8.4 gene appears to be absent from the environmental mycobacterial species examined thus far, including Mycobacterium smegmatis, Mycobacterium gordonae, Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium scrofulaceum. Recombinant Mtb 8.4 Ag induced significant proliferation as well as production of IFN-gamma, IL-10, and TNF-alpha, but not IL-5, from human PBMC isolated from PPD-positive healthy donors. Mtb 8.4 did not stimulate PBMC from PPD-negative donors. Furthermore, immunogenicity studies in mice indicate that Mtb 8.4 elicits a Th1 cytokine profile, which is considered important for protective immunity to tuberculosis. Collectively, these results demonstrate that Mtb 8.4 is an immunodominant T cell Ag of M. tuberculosis.


Assuntos
Antígenos de Bactérias/genética , Antígenos de Bactérias/imunologia , Proteínas de Bactérias , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/imunologia , Sequência de Aminoácidos , Animais , Antígenos de Bactérias/administração & dosagem , Sequência de Bases , Western Blotting , Clonagem Molecular , Meios de Cultura/análise , Citocinas/metabolismo , Genes Bacterianos , Humanos , Injeções Subcutâneas , Leucócitos Mononucleares/imunologia , Linfonodos/imunologia , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Dados de Sequência Molecular , Peso Molecular , Mycobacterium avium/imunologia , Mycobacterium bovis/imunologia
13.
Infect Immun ; 66(9): 4208-14, 1998 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9712769

RESUMO

Proteins secreted into the culture medium by Mycobacterium tuberculosis are thought to play an important role in the development of protective immune responses. In this report, we describe the molecular cloning of a novel, low-molecular-weight antigen (MTB12) secreted by M. tuberculosis. Sequence analysis of the MTB12 gene indicates that the protein is initially synthesized as a 16.6-kDa precursor protein containing a 48-amino-acid hydrophobic leader sequence. The mature, fully processed form of MTB12 protein found in culture filtrates has a molecular mass of 12. 5 kDa. MTB12 protein constitutes a major component of the M. tuberculosis culture supernatant and appears to be at least as abundant as several other well-characterized culture filtrate proteins, including members of the 85B complex. MTB12 is encoded by a single-copy gene which is present in both virulent and avirulent strains of the M. tuberculosis complex, the BCG strain of M. bovis, and M. leprae. Recombinant MTB12 containing an N-terminal six-histidine tag was expressed in Escherichia coli and purified by affinity chromatography. Recombinant MTB12 protein elicited in vitro proliferative responses from the peripheral blood mononuclear cells of a number of purified protein derivative-positive (PPD+) human donors but not from PPD- donors.


Assuntos
Proteínas de Bactérias/genética , Mycobacterium tuberculosis/genética , Sequência de Aminoácidos , Animais , Antígenos de Bactérias/imunologia , Antígenos de Bactérias/isolamento & purificação , Proteínas de Bactérias/imunologia , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/metabolismo , Sequência de Bases , Western Blotting , Células Cultivadas , Clonagem Molecular , DNA Bacteriano , Expressão Gênica , Humanos , Leucócitos Mononucleares/metabolismo , Dados de Sequência Molecular , Peso Molecular , Coelhos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/isolamento & purificação , Proteínas Recombinantes de Fusão/metabolismo , Homologia de Sequência de Aminoácidos
14.
J Exp Med ; 187(10): 1633-40, 1998 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-9584141

RESUMO

Previous studies in murine models, including those using the beta2 microglobulin knockout mouse, have suggested an important role for CD8+ T cells in host defense to Mycobacterium tuberculosis (Mtb). At present, little is understood about these cells in the human immune response to tuberculosis. This report demonstrates the existence of human Mtb-reactive CD8+ T cells. These cells are present preferentially in persons infected with Mtb and produce interferon gamma in response to stimulation with Mtb-infected target cells. Recognition of Mtb-infected cells by these CD8+ T cells is restricted neither by the major histocompatibility complex (MHC) class I A, B, or C alleles nor by CD1, although it is inhibited by anti-MHC class I antibody. The Mtb-specific CD8+ T cells recognize an antigen which is generated in the proteasome, but which does not require transport through the Golgi-ER. The data suggest the possible use of nonpolymorphic MHC class Ib antigen presenting structures other than CD1.


Assuntos
Apresentação de Antígeno , Linfócitos T CD8-Positivos/imunologia , Mycobacterium tuberculosis/imunologia , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacologia , Sequência de Aminoácidos , Animais , Apresentação de Antígeno/efeitos dos fármacos , Linfócitos T CD8-Positivos/microbiologia , Cloroquina/farmacologia , Inibidores de Cisteína Proteinase/farmacologia , Humanos , Cooperação Linfocítica , Camundongos , Dados de Sequência Molecular , Tuberculose/imunologia
16.
J Immunol ; 160(5): 2374-9, 1998 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-9498779

RESUMO

CTL, both CD4+ and CD8+, are essential in the eradication of intracellular pathogens. Data generated using murine T cells have suggested a critical role for CD95 (Fas, Apo-1) in CD4+ T cell-induced apoptosis of target cells. In contrast, CD8+ CTL predominantly use the perforin/granzyme lytic pathway. At present little is known about the mechanism of CD4+ CTL lytic function during intracellular infection in humans. We have used human CD4+ T cells specific for purified protein derivative (PPD) of Mycobacterium tuberculosis to explore whether CD95 is the dominant cytolytic mechanism. PPD-reactive CD4+ clones efficiently lysed Ag-pulsed autologous monocytes, adherent macrophages, and EBV-transformed B cells. Addition of an antagonistic CD95 Ab had a minimal effect on cytolysis, whereas addition of MgEGTA to block perforin/granzyme resulted in complete inhibition of killing. In contrast, lysis of activated peripheral blood B cells could be partially blocked with the antagonistic CD95 Ab. Supporting these observations, monocytes, macrophages, and EBV-transformed B cells were not lysed by an agonistic CD95 Ab. Activated B cells were readily lysed by the agonistic CD95 Ab. T cell clones triggered through the TCR with anti-CD3 were capable of lysing the CD95-sensitive Jurkat T cell line in a CD95-dependent manner, but were also able to release granzymes. We conclude that human CD4+ T cells are capable of lysing PPD-pulsed targets using both perforin/granzyme and CD95 pathways. The contribution of CD95 is strictly dependent on target cell susceptibility to CD95-mediated killing.


Assuntos
Linfócitos T CD4-Positivos/imunologia , Citotoxicidade Imunológica , Linfócitos T Citotóxicos/imunologia , Tuberculina/imunologia , Receptor fas/fisiologia , Anticorpos Bloqueadores/farmacologia , Linfócitos T CD4-Positivos/enzimologia , Linhagem Celular , Células Clonais , Testes Imunológicos de Citotoxicidade , Epitopos/imunologia , Esterases/metabolismo , Proteína Ligante Fas , Humanos , Células Jurkat , Ativação Linfocitária/genética , Macrófagos/imunologia , Glicoproteínas de Membrana/genética , Monócitos/imunologia , Perforina , Proteínas Citotóxicas Formadoras de Poros , RNA Mensageiro/biossíntese , Linfócitos T Citotóxicos/enzimologia , Receptor fas/biossíntese , Receptor fas/imunologia
17.
J Immunol ; 160(5): 2037-41, 1998 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-9498737

RESUMO

It has been proposed that the induction of cellular immunity and resistance to intracellular pathogens is dependent upon CD40 ligand (CD40L). In the present study we show that this proposal is not ubiquitously supported. Mice genetically deficient in CD40L (CD40LKO) were resistant to i.v. infection with Mycobacterium tuberculosis when assessed by survival and bacteriologic burden in the spleen, liver, and lungs. Infected CD40LKO mice developed granulomas that lacked epithelioid cells and were less numerous and markedly smaller than those observed in control mice. Upon stimulation with purified protein derivative of M. tuberculosis, CD4+ T cells from infected CD40LKO mice proliferated and produced high levels of IFN-gamma but not IL-4. Finally, spleen cells from CD40LKO mice stimulated with M. tuberculosis produced IL-12, TNF, and nitric oxide levels comparable to those produced by control cells. In contrast to original proposals, these data clearly show that protective Thl immunity can be achieved against intracellular pathogens (e.g., Mycobacterium) independently of CD40L.


Assuntos
Antígenos CD40/fisiologia , Glicoproteínas de Membrana/fisiologia , Mycobacterium tuberculosis/imunologia , Tuberculose/imunologia , Animais , Anticorpos Antibacterianos/biossíntese , Anticorpos Antibacterianos/sangue , Antígenos CD40/genética , Ligante de CD40 , Imunidade Celular/genética , Imunidade Inata/genética , Interleucina-12/biossíntese , Ligantes , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Tuberculose/genética , Tuberculose/microbiologia , Tuberculose/patologia , Fator de Necrose Tumoral alfa/biossíntese
18.
Eur J Immunol ; 27(12): 3161-5, 1997 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9464801

RESUMO

Dendritic cells (DC) are considered to be the most potent antigen-presenting cells (APC) in the immune system. In this study, we analyzed the regulation of apoptosis of human peripheral blood-derived DC. DC were generated from adherent peripheral blood mononuclear cells that had been cultured for 7 days with granulocyte-macrophage colony-stimulating factor and interleukin-4. These cells displayed phenotypic properties of DC, including dendritic processes, expression of CD1a and lack of expression of CD14, and were very potent at presenting soluble antigens to T cells. Blood-derived DC were demonstrated to express the Fas/CD95 antigen and an agonist antibody to CD95 strongly induced apoptotic cell death in these cells. Soluble trimeric CD40 ligand potently inhibited both CD95-mediated and spontaneous apoptosis in DC. The data suggest that interactions between members of the tumor necrosis factor family of ligands expressed by T cells with their receptors on DC play an important role in the regulation of apoptosis in DC during antigen presentation and may, therefore, regulate the duration of T cell expansion and cytokine production.


Assuntos
Apoptose/imunologia , Células Dendríticas/patologia , Glicoproteínas de Membrana/imunologia , Receptor fas/imunologia , Apoptose/efeitos dos fármacos , Ligante de CD40 , Células Cultivadas , Células Dendríticas/imunologia , Humanos , Glicoproteínas de Membrana/farmacologia , Linfócitos T/imunologia , Receptor fas/farmacologia
19.
J Virol ; 70(8): 5557-63, 1996 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8764069

RESUMO

The Epstein-Barr virus BZLF2 gene encodes a glycoprotein that associates with gH and gL and facilitates the infection of B lymphocytes. In order to determine whether the BZLF2 protein recognizes a B-cell-specific surface antigen, a soluble protein containing the extracellular portion of the BZLF2 protein linked to the Fc portion of human immunoglobulin G1 (BZLF2.Fc) was expressed from mammalian cells. BZLF2.Fc was used in an expression cloning system and found to bind to a beta-chain allele of the HLA-DR locus of the class II major histocompatibility complex (MHC). Analysis of amino- and carboxy-terminal deletion mutants of the BZLF2.Fc protein indicated that the first 90 amino acids of BZLF2.Fc are not required for HLA-DR beta-chain recognition. Site-directed mutagenesis of an HLA-DR beta-chain cDNA and subsequent immunoprecipitation of expressed mutant beta-chain proteins using BZLF2.Fc indicated that the beta1 domain, which participates in the formation of peptide binding pockets, is required for BZLF2.Fc recognition. The addition of BZLF2.Fc to sensitized peripheral blood mononuclear cells in vitro abolished their proliferative response to antigen and inhibited cytokine-dependent cytotoxic T-cell generation in mixed lymphocyte cultures. Flow-cytometric analysis of Akata cells induced to express late Epstein-Barr virus antigens indicated that expression of BZLF2 did not result in reduced surface expression levels of MHC class II. The ability of BZLF2.Fc to bind to the HLA-DR beta chain suggests that the BZLF2 protein may interact with MHC class II on the surfaces of B cells.


Assuntos
Glicoproteínas , Antígenos HLA-DR/imunologia , Infecções por Herpesviridae/imunologia , Herpesvirus Humano 4/imunologia , Linfócitos/virologia , Infecções Tumorais por Vírus/imunologia , Proteínas Virais/imunologia , Sequência de Aminoácidos , Apresentação de Antígeno , Linhagem Celular , Infecções por Herpesviridae/virologia , Humanos , Linfócitos/imunologia , Dados de Sequência Molecular , Ligação Proteica , Infecções Tumorais por Vírus/virologia , Proteínas Virais/genética
20.
J Immunol ; 156(9): 3260-6, 1996 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-8617948

RESUMO

Herpesvirus saimiri (HVS) is an oncogenic, lymphotropic, gamma-herpesvirus that transforms human and simian T cells in vitro and causes lymphomas and leukemias in various species of New World primates. Nucleotide sequence analysis of the HVS genome revealed an open reading frame with 22% amino acid identity to the mouse mammary tumor virus 7 superantigen. In this study, we demonstrate that this open reading frame, HVS14, encodes a heavily glycosylated protein that is secreted. Both the HVS14 present in the supernatant of transfected cells and a chimeric HVS14.Fc fusion protein were found to bind to heterodimeric MHC class II HLA-DR molecules. The supernatant from HVS14-transfected cells induced the proliferation of human PBMC, which could be specifically inhibited by HVS14-specific mAbs. Purified peripheral blood T cells were induced to proliferate in the presence of accessory cells and HVS14-containing supernatant. Whereas the HVS14 protein stimulated T cell proliferation, the HVS14.Fc fusion protein blocked proliferative responses to soluble Ags in vitro. Collectively, these data indicate that HVS14 can function as an immunomodulator that may contribute to the immunopathology of HVS infection.


Assuntos
Herpesvirus Saimiriíneo 2/genética , Herpesvirus Saimiriíneo 2/isolamento & purificação , Antígenos de Histocompatibilidade Classe II/metabolismo , Ativação Linfocitária/efeitos dos fármacos , Fases de Leitura Aberta/imunologia , Linfócitos T/virologia , Proteínas Virais/genética , Proteínas Virais/farmacologia , Sistema Livre de Células/imunologia , Clonagem Molecular , Genes Virais/imunologia , Glicosilação , Herpesvirus Saimiriíneo 2/imunologia , Humanos , Linfoma , Proteínas de Membrana/metabolismo , Ligação Proteica/imunologia , Proteínas Recombinantes de Fusão/biossíntese , Linfócitos T/imunologia , Toxoide Tetânico/antagonistas & inibidores , Transfecção/imunologia , Tuberculina/efeitos dos fármacos , Tuberculina/farmacologia , Células Tumorais Cultivadas , Proteínas Virais/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA